The neuroprotection market’s projected expansion to US$ 38.75 Billion by 2031 at a 7.5% CAGR is underpinned by powerful structural and clinical drivers. Among these are the rising incidence of neurological disorders, growing healthcare expenditure, and breakthroughs in neuroscience research that have deepened understanding of neuronal injury mechanisms. Aging...